Abstract
Parasitic diseases cause significant global morbidity and mortality in humans and livestock annually. Accurate diagnosis of protozoan parasites hinges on understanding their localization within the host’s body. Protozoan parasites have high biotic potential, often expelled from the host through excretions such as feces, blood, or fluids, necessitating thorough examination. They inhabit various host sites: alimentary tracts (flagellates, coccidia), liver (Histomonas, Leishmania), spleen (Theileria), kidneys (coccidia), genital tract (Trichomonads), brain (Toxoplasma), blood (hemoprotozoa), reticuloendothelial system (Leishmania), muscles (Sarcocystis), and skin (Leishmania). Diagnosis involves sample examination, culture, blood tests, and molecular techniques. Chemotherapy’s challenges prompt interest in nanoparticle-based therapies. Nanotechnology manipulates particles at atomic scales, explored in treating protozoan diseases. This chapter provides a nanotech overview in managing human protozoan diseases, holding promise for innovative diagnosis and treatments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Recent Developments in Nanomaterial-based Sensing of Human Pathogens
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
